Analysis of Attitudes and Practices towards the Influenza Vaccine in High-Risk Adults in Poland
This study aimed to understand Poles' attitudes and beliefs towards influenza vaccinations in the flu season of 2022-2023, especially among individuals at risk of flu complications. The cross-sectional survey-based study was carried out on a sample of 810 respondents. The questionnaire was disseminated electronically using social media and e-mail. The majority of respondents (71%) could identify "high-risk groups" recommended for influenza vaccination, and 52.01% of respondents reported receiving influenza vaccination at some point in the past, with 32.12% receiving it in the 2022-2023 flu season and 41.09% in the 2021-2022 season. The majority of respondents declaring acceptance of the vaccine for the 2022-2023 season were in the high-risk group. Only 17.28% of respondents declared receiving both influenza and SARS-CoV-2 vaccines in the 2022-2023 season, with the vast majority being respondents from the "high-risk group" (p < 0.0001). Only 26.12% of respondents declared their intention to continue influenza vaccination in the future. Of those expressing the intention to get vaccinated against the influenza virus in future seasons, 46.79% were from the "high-risk group" (p = 0.0087). Results suggest the need for further interaction and education with healthcare providers and targeted informational efforts for at-risk groups regarding the benefits of flu vaccination.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:12 |
---|---|
Enthalten in: |
Vaccines - 12(2024), 3 vom: 21. März |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Kopciuch, Dorota [VerfasserIn] |
---|
Links: |
---|
Themen: |
Attitudes |
---|
Anmerkungen: |
Date Revised 30.03.2024 published: Electronic Citation Status PubMed-not-MEDLINE |
---|
doi: |
10.3390/vaccines12030341 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM370335236 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM370335236 | ||
003 | DE-627 | ||
005 | 20240331002053.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240329s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.3390/vaccines12030341 |2 doi | |
028 | 5 | 2 | |a pubmed24n1357.xml |
035 | |a (DE-627)NLM370335236 | ||
035 | |a (NLM)38543975 | ||
035 | |a (PII)341 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Kopciuch, Dorota |e verfasserin |4 aut | |
245 | 1 | 0 | |a Analysis of Attitudes and Practices towards the Influenza Vaccine in High-Risk Adults in Poland |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 30.03.2024 | ||
500 | |a published: Electronic | ||
500 | |a Citation Status PubMed-not-MEDLINE | ||
520 | |a This study aimed to understand Poles' attitudes and beliefs towards influenza vaccinations in the flu season of 2022-2023, especially among individuals at risk of flu complications. The cross-sectional survey-based study was carried out on a sample of 810 respondents. The questionnaire was disseminated electronically using social media and e-mail. The majority of respondents (71%) could identify "high-risk groups" recommended for influenza vaccination, and 52.01% of respondents reported receiving influenza vaccination at some point in the past, with 32.12% receiving it in the 2022-2023 flu season and 41.09% in the 2021-2022 season. The majority of respondents declaring acceptance of the vaccine for the 2022-2023 season were in the high-risk group. Only 17.28% of respondents declared receiving both influenza and SARS-CoV-2 vaccines in the 2022-2023 season, with the vast majority being respondents from the "high-risk group" (p < 0.0001). Only 26.12% of respondents declared their intention to continue influenza vaccination in the future. Of those expressing the intention to get vaccinated against the influenza virus in future seasons, 46.79% were from the "high-risk group" (p = 0.0087). Results suggest the need for further interaction and education with healthcare providers and targeted informational efforts for at-risk groups regarding the benefits of flu vaccination | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a attitudes | |
650 | 4 | |a high-risk groups | |
650 | 4 | |a influenza | |
650 | 4 | |a practice | |
650 | 4 | |a vaccines | |
700 | 1 | |a Hoffmann, Karolina |e verfasserin |4 aut | |
700 | 1 | |a Kus, Krzysztof |e verfasserin |4 aut | |
700 | 1 | |a Koligat-Seitz, Agnieszka |e verfasserin |4 aut | |
700 | 1 | |a Ratajczak, Piotr |e verfasserin |4 aut | |
700 | 1 | |a Nowakowska, Elżbieta |e verfasserin |4 aut | |
700 | 1 | |a Paczkowska, Anna |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Vaccines |d 2012 |g 12(2024), 3 vom: 21. März |w (DE-627)NLM239212347 |x 2076-393X |7 nnns |
773 | 1 | 8 | |g volume:12 |g year:2024 |g number:3 |g day:21 |g month:03 |
856 | 4 | 0 | |u http://dx.doi.org/10.3390/vaccines12030341 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 12 |j 2024 |e 3 |b 21 |c 03 |